Norris Perne & French LLP Abbott Laboratories Transaction History

Norris Perne & French LLP

  • $1.3 Billion
  • Q2 2024

A detailed history of Norris Perne & French LLP transactions in Abbott Laboratories stock. As of the latest transaction made, Norris Perne & French LLP holds 228,760 shares of ABT stock, worth $23.8 Million. This represents 1.83% of its overall portfolio holdings.

Number of Shares
228,760
Previous 144,344 58.48%
Holding current value
$23.8 Million
Previous $16.4 Million 44.89%
% of portfolio
1.83%
Previous 1.26%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024
BUY
$100.73 - $112.44 $8.5 Million - $9.49 Million
84,416 Added 58.48%
228,760 $23.8 Million
Q1 2024

Apr 16, 2024
BUY
$109.52 - $120.96 $192,864 - $213,010
1,761 Added 1.24%
144,344 $16.4 Million
Q4 2023

Jan 22, 2024
BUY
$90.19 - $110.4 $212,758 - $260,433
2,359 Added 1.68%
142,583 $15.7 Million
Q3 2023

Oct 18, 2023
BUY
$95.53 - $114.62 $251,339 - $301,565
2,631 Added 1.91%
140,224 $13.6 Million
Q2 2023

Jul 19, 2023
BUY
$100.78 - $112.29 $160,038 - $178,316
1,588 Added 1.17%
137,593 $15 Million
Q1 2023

Apr 20, 2023
BUY
$96.86 - $114.01 $105,093 - $123,700
1,085 Added 0.8%
136,005 $13.8 Million
Q4 2022

Jan 24, 2023
SELL
$95.06 - $111.52 $316,264 - $371,027
-3,327 Reduced 2.41%
134,920 $0
Q3 2022

Oct 13, 2022
BUY
$96.76 - $112.03 $153,654 - $177,903
1,588 Added 1.16%
138,247 $13.4 Million
Q2 2022

Aug 11, 2022
BUY
$102.07 - $123.37 $210,978 - $255,005
2,067 Added 1.54%
136,659 $14.8 Million
Q1 2022

Apr 26, 2022
BUY
$114.02 - $139.04 $159,285 - $194,238
1,397 Added 1.05%
134,592 $15.9 Million
Q4 2021

Jan 26, 2022
BUY
$115.53 - $141.46 $173,063 - $211,907
1,498 Added 1.14%
133,195 $18.7 Million
Q3 2021

Oct 26, 2021
BUY
$116.66 - $129.06 $346,713 - $383,566
2,972 Added 2.31%
131,697 $15.6 Million
Q2 2021

Jul 20, 2021
BUY
$105.79 - $124.53 $373,544 - $439,715
3,531 Added 2.82%
128,725 $14.9 Million
Q1 2021

Apr 30, 2021
BUY
$108.84 - $128.23 $1.8 Million - $2.12 Million
16,494 Added 15.17%
125,194 $15 Million
Q4 2020

Jan 27, 2021
BUY
$105.0 - $114.42 $254,835 - $277,697
2,427 Added 2.28%
108,700 $11.9 Million
Q3 2020

Oct 26, 2020
SELL
$91.64 - $111.29 $89,440 - $108,619
-976 Reduced 0.91%
106,273 $11.6 Million
Q2 2020

Jul 23, 2020
BUY
$76.57 - $98.0 $106,355 - $136,122
1,389 Added 1.31%
107,249 $9.81 Million
Q1 2020

Apr 16, 2020
SELL
$62.82 - $91.86 $82,859 - $121,163
-1,319 Reduced 1.23%
105,860 $8.35 Million
Q4 2019

Jan 22, 2020
SELL
$78.51 - $87.4 $9.63 Million - $10.7 Million
-122,704 Reduced 53.38%
107,179 $9.31 Million
Q3 2019

Oct 24, 2019
SELL
$81.84 - $88.74 $81,103 - $87,941
-991 Reduced 0.43%
229,883 $19.2 Million
Q2 2019

Jul 19, 2019
SELL
$72.88 - $85.0 $13,191 - $15,385
-181 Reduced 0.08%
230,874 $19.4 Million
Q1 2019

Apr 29, 2019
SELL
$66.22 - $80.06 $3.46 Million - $4.18 Million
-52,197 Reduced 18.43%
231,055 $18.5 Million
Q4 2018

Jan 28, 2019
BUY
$65.56 - $74.27 $153,475 - $173,866
2,341 Added 0.83%
283,252 $20.5 Million
Q3 2018

Oct 29, 2018
BUY
$60.81 - $73.36 $5.97 Million - $7.2 Million
98,140 Added 53.7%
280,911 $20.6 Million
Q2 2018

Jul 24, 2018
BUY
$57.57 - $63.54 $329,012 - $363,131
5,715 Added 3.23%
182,771 $11.1 Million
Q1 2018

Apr 17, 2018
BUY
$56.27 - $63.62 $109,839 - $124,186
1,952 Added 1.11%
177,056 $10.6 Million
Q4 2017

Jan 23, 2018
SELL
$53.68 - $57.47 $299,104 - $320,222
-5,572 Reduced 3.08%
175,104 $9.99 Million
Q3 2017

Nov 01, 2017
BUY
$48.06 - $53.64 $8.68 Million - $9.69 Million
180,676
180,676 $9.64 Million

Others Institutions Holding ABT

# of Institutions
3,114
Shares Held
1.29B
Call Options Held
8.43M
Put Options Held
8.19M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $182B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Norris Perne & French LLP Portfolio

Follow Norris Perne & French LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norris Perne & French LLP, based on Form 13F filings with the SEC.

News

Stay updated on Norris Perne & French LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email